IMA Pharmasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2009-04-07
Share capital
309,375.00 PLN
Registered address
ul. Kinga C. Gillette 11, 94-406 Łódź, Poland
Electronic delivery address
AE:PL-71415-26861-EUIWW-36

Financials

Revenue history (in k)

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 16 days late).

  • 202525/05/2026
  • 202402/07/2025
  • 202324/04/2024
  • 202226/06/2023
  • 202131/07/2022
  • 202014/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 38%
Division · Retail trade2,644 / 9,913
Top 27%
City · Łódź925 / 8,065
Top 11%
Voivodeship · Łódzkie2,239 / 15,300
Top 15%
Country · Poland41,930 / 297,935
Top 14%

Results vs industry

Revenue
This companyUSD 3.59mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 9.04kMedianUSD 20.70kAverageUSD 86.70k
Operating costs
This companyUSD 3.57mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 882.30kMedianUSD 543.65kAverageUSD 1.76m

National Health Fund (NFZ) contracts

IMA Pharma has been an NFZ healthcare provider since 2019. In 2026 it is performing 3 contracts with a total value of USD 94.54. All its contracts were worth USD 9.47k in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmesmazowieckie1USD 94.54
Other services provided in pharmaciesmazowieckie2USD 0.00

Authorized Representatives

Rafał Emil Jarząbek – Vice President of the Management Board
Igor Wojciech Jachorski – President of the Management Board
Paulina Świderek – Vice President of the Management Board

Manner of representation

The management board consists of at least two members. Where a multi-member management board is appointed, two members of the management board acting jointly, or one member of the management board acting together with a commercial proxy, are authorised to make declarations of will on behalf of the company.

Ownership

OwnerSharesShare valueStake
627$63,512.9776%
198$20,056.7324%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2004-03-31.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,204
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,336
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,057

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.
Awicennasp. j.

Change history

DateEvent
2024-06-12Address change
2024-06-12Share capital increase
2022-11-16PKD change
2019-03-15Address change
2017-04-10Share capital reduction

FAQ

Last updated: 2026-05-25